Search Results

January 2022 "After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position

News Duke University Celebrates Nobel Prize Winner Robert Lefkowitz’s 50 Years of Scientific Discovery Novo Nordisk Foundation Grants Fuel Exciting GPCR and Signaling Protein Research Tools First-In-Class Drug

👉 Most biotech founders  do not realize they are in trouble when the money runs out. Biotech founders rarely notice this moment because nothing visibly breaks. For Biotech Founders, the real danger is not running out of money, but losing financial control early founders ignore their finances. This is where many biotech founders lose visibility.

2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck Foundation Fellowship, and Novo Nordisk Foundation Ascending Investigator awards.

Nordisk, and into biotech at InterAx — where the next challenge is using functional fingerprints to After running her own academic group in Graz, she spent six and a half years at Novo Nordisk in early Nordisk, putting it in an animal, and watching the effect come back exactly as predicted. After working in the US and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer.

Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US Jacek shared his experience of working with Piketa and how he found a job in Seda's lab at Cambridge,